Home / Rivastigmine / United States
US ATC N06DA03 · updated 2 Nov 2026
Rivastigmine shortage in United States
Is there a Rivastigmine shortage in United States?
Yes. As of 2 Nov 2026, 1 Rivastigmine product is reported short in United States, the first since 18 Sep 2026. No return date has been given. Main reason: not stated.
Also short in Italy, Spain, Austria, Belgium, Sweden. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Rivastigmine, Film, Extended Release, 4.6 mg/24 h (NDC 0378-9070-93) discontinuation | Mylan Pharmaceuticals Inc., a Viatris Company | 18 Sep 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).